Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2013-09-29 01:30Week in Review: Amgen Partners with ShanghaiTech on China R&D Center
2013-09-28 01:30Boehringer Ingelheim Opens Expanded Shanghai Production Facility
2013-09-27 01:30Sinochem Jiangsu to Distribute Amerigen Drug in China
2013-09-26 01:30Shenzhen Proposes Creation of New Biotech Park and more...
2013-09-25 01:30GSK's China Revenues May Be Down by 30% in Q3
2013-09-24 01:30Mindray Buys Australia/New Zeeland Medical Device Distributor
2013-09-22 01:30Week in Review: CanSino Lands $10 Million Investment from Lilly
2013-09-21 01:30Another China Bribery Rumor Involving Novartis
2013-09-20 01:30Boston Scientific Opens Training Center in Shanghai
2013-09-19 01:30Huahai Pharma China-Approved to Produce AIDS Treatment
2013-09-18 01:30SIMM and Servier Collaborate on China Development for Cancer Drug
2013-09-17 01:30Tianjin CanSino Biotech Raises $10 Million from Lilly Asia Ventures and more...
2013-09-15 01:30Week in Review: Walvax Rumored to Acquire Genor BioPharma Soon
2013-09-14 01:30BGI Tech Forms Collaboration with San Antonio Cancer Genome Project and more...
2013-09-13 01:30Beijing's CANbridge Gains China Rights to Cancer Drug from Azaya and more...
2013-09-12 01:30Genor BioPharma of Shanghai May Be Acquired and IPO'd and more...
2013-09-11 01:30MicroConstants China In-Licenses Liver Cancer Drug and more...
2013-09-10 01:30DelMar and Guangxi Wuzhou Pharmas Form Advisory Board for Cancer Drug
2013-09-08 01:30Week in Review: BGI Shenzhen Planning Partial IPO
2013-09-07 01:30Hua Medicine Begins Phase I Trial of Novel Diabetes Treatment
2013-09-06 01:30China Says GlaxoSmithKline Deserves an "Astronomical" Fine
2013-09-05 01:30Eddingpharm Gains China Rights for Cancer Drug from Syndax
2013-09-04 01:30BGI Shenzhen Plans IPO and more...
2013-09-01 01:30Week in Review: Simcere Pharma Accepts $495 Million Go-Private Deal

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC